Erica is a physician with experience in biological research, specializing in molecular biology, microbiology, and biochemical assays. Her skills include PCR, gel electrophoresis, cloning, cell culture, enzymology, genomic sequencing, CRISPR, experimental design, and data analysis.

Her research includes assessing the cytotoxicity of novel polymer compounds for biomedical applications, using cell culture assays and viability measurements to ensure safe medical material development. Separately, she applied CRISPR-Cas9 to disrupt metabolic genes in E. coli, analyzing enzyme regulation and growth dynamics, and optimized protein purification protocols to enhance the yield and purity of recombinant enzymes with chromatograpy. Erica applies her knowledge of human physiology, pathology, and clinical reasoning to support research and drug discovery efforts. She is adept at using basic computational tools for data analysis, transforming complex biological data into actionable insights. Holding a BSc degree in Zoology/Animal Biology and a DO degree from the University of New England, Erica brings a practical, research-driven approach to advancing biotechnology and medical solutions.